STOCK TITAN

[Form 4] Hippo Holdings Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Michael Stienstra, General Manager & Chief Insurance Officer of Hippo Holdings Inc. (HIPO), reported a sale of 2,341 shares of Hippo common stock on 08/15/2025 at a price of $30.91 per share. After the transaction he beneficially owned 78,396 shares, which the filer notes includes 46,271 RSUs. The Form 4 was signed by an attorney-in-fact on 08/18/2025. The filing discloses the transaction code F indicating a sale, and provides the post-transaction beneficial ownership figure but no additional context about purpose of sale or planned transactions.

Michael Stienstra, General Manager e Chief Insurance Officer di Hippo Holdings Inc. (HIPO), ha venduto 2.341 azioni ordinarie di Hippo il 15/08/2025 al prezzo di $30,91 per azione. Dopo l'operazione possedeva beneficiariamente 78.396 azioni, delle quali 46.271 risultano essere RSU. Il Modulo 4 è stato firmato da un procuratore il 18/08/2025. La comunicazione riporta il codice transazione F per vendita e indica la detenzione post-operazione, senza fornire ulteriori dettagli sul motivo della vendita o su eventuali operazioni future.

Michael Stienstra, General Manager y Chief Insurance Officer de Hippo Holdings Inc. (HIPO), informó la venta de 2.341 acciones ordinarias de Hippo el 15/08/2025 a $30,91 por acción. Tras la transacción poseía beneficiariamente 78.396 acciones, que incluyen 46.271 RSU. El Formulario 4 fue firmado por un apoderado el 18/08/2025. La presentación muestra el código de transacción F indicando una venta y proporciona la titularidad después de la operación, sin más contexto sobre el propósito de la venta ni transacciones planificadas.

Michael Stienstra, Hippo Holdings Inc. (HIPO)의 General Manager 겸 Chief Insurance Officer는 2025-08-15에 Hippo 보통주 2,341주를 주당 $30.91에 매도했다고 보고했습니다. 거래 후 그는 78,396주를 실질적으로 보유하고 있었으며, 그 중 46,271주는 RSU에 해당한다고 기재되어 있습니다. Form 4는 2025-08-18에 대리인이 서명했습니다. 제출서에는 매도를 의미하는 거래 코드 F가 표기되어 있으며, 거래 후 소유 지분만 기재되어 있을 뿐 판매 목적이나 향후 계획에 대한 추가 설명은 없습니다.

Michael Stienstra, General Manager et Chief Insurance Officer de Hippo Holdings Inc. (HIPO), a déclaré la vente de 2 341 actions ordinaires de Hippo le 15/08/2025 au prix de 30,91 $ par action. Après la transaction, il détenait bénéficiairement 78 396 actions, dont 46 271 sous forme de RSU. Le formulaire 4 a été signé par un mandataire le 18/08/2025. Le dépôt indique le code de transaction F pour vente et fournit la participation bénéficiaire post-transaction, sans autre précision sur le motif de la vente ni sur d'éventuelles opérations projetées.

Michael Stienstra, General Manager und Chief Insurance Officer von Hippo Holdings Inc. (HIPO), meldete den Verkauf von 2.341 Stammaktien von Hippo am 15.08.2025 zum Preis von $30,91 pro Aktie. Nach der Transaktion hielt er wirtschaftlich 78.396 Aktien, wovon 46.271 als RSUs ausgewiesen sind. Das Formular 4 wurde am 18.08.2025 von einem Bevollmächtigten unterzeichnet. Die Meldung weist den Transaktionscode F für Verkauf aus und nennt die nachträgliche wirtschaftliche Beteiligung, liefert jedoch keine weiteren Angaben zum Verkaufsgrund oder geplanten Transaktionen.

Positive
  • Timely disclosure of insider transaction on Form 4, meeting Section 16 reporting requirements
  • Post-transaction beneficial ownership is clearly reported, including a breakdown note that 46,271 shares are RSUs
Negative
  • Insider disposition of 2,341 shares at $30.91 could be viewed negatively by some investors
  • No explanation provided for the sale (e.g., not identified as 10b5-1), limiting transparency on motivations

Insights

TL;DR: Insider sale of 2,341 shares at $30.91; ownership remains sizable with 78,396 shares including 46,271 RSUs.

The reported sale is a straightforward Section 16 disclosure showing an insider disposition recorded under transaction code F. The size of the sale (2,341 shares) appears modest relative to the remaining beneficial position; the report explicitly states the total post-sale holdings and the portion attributable to RSUs, aiding transparency. There is no additional financial context, such as pattern of sales or reason for the disposition, so material implications for valuation are limited based solely on this filing.

TL;DR: Timely Form 4 filing shows an insider sale but provides no explanation; compliance disclosure is met.

The Form 4 meets disclosure obligations by reporting the sale amount, price, date, and resulting beneficial ownership. The filing was executed by an attorney-in-fact and includes a remark that 46,271 shares are RSUs, which is useful for assessing vested versus earned equity. From a governance perspective, the filing raises no immediate compliance concerns but lacks narrative on whether the sale was part of a 10b5-1 plan or routine liquidity, limiting interpretive value for stakeholders.

Michael Stienstra, General Manager e Chief Insurance Officer di Hippo Holdings Inc. (HIPO), ha venduto 2.341 azioni ordinarie di Hippo il 15/08/2025 al prezzo di $30,91 per azione. Dopo l'operazione possedeva beneficiariamente 78.396 azioni, delle quali 46.271 risultano essere RSU. Il Modulo 4 è stato firmato da un procuratore il 18/08/2025. La comunicazione riporta il codice transazione F per vendita e indica la detenzione post-operazione, senza fornire ulteriori dettagli sul motivo della vendita o su eventuali operazioni future.

Michael Stienstra, General Manager y Chief Insurance Officer de Hippo Holdings Inc. (HIPO), informó la venta de 2.341 acciones ordinarias de Hippo el 15/08/2025 a $30,91 por acción. Tras la transacción poseía beneficiariamente 78.396 acciones, que incluyen 46.271 RSU. El Formulario 4 fue firmado por un apoderado el 18/08/2025. La presentación muestra el código de transacción F indicando una venta y proporciona la titularidad después de la operación, sin más contexto sobre el propósito de la venta ni transacciones planificadas.

Michael Stienstra, Hippo Holdings Inc. (HIPO)의 General Manager 겸 Chief Insurance Officer는 2025-08-15에 Hippo 보통주 2,341주를 주당 $30.91에 매도했다고 보고했습니다. 거래 후 그는 78,396주를 실질적으로 보유하고 있었으며, 그 중 46,271주는 RSU에 해당한다고 기재되어 있습니다. Form 4는 2025-08-18에 대리인이 서명했습니다. 제출서에는 매도를 의미하는 거래 코드 F가 표기되어 있으며, 거래 후 소유 지분만 기재되어 있을 뿐 판매 목적이나 향후 계획에 대한 추가 설명은 없습니다.

Michael Stienstra, General Manager et Chief Insurance Officer de Hippo Holdings Inc. (HIPO), a déclaré la vente de 2 341 actions ordinaires de Hippo le 15/08/2025 au prix de 30,91 $ par action. Après la transaction, il détenait bénéficiairement 78 396 actions, dont 46 271 sous forme de RSU. Le formulaire 4 a été signé par un mandataire le 18/08/2025. Le dépôt indique le code de transaction F pour vente et fournit la participation bénéficiaire post-transaction, sans autre précision sur le motif de la vente ni sur d'éventuelles opérations projetées.

Michael Stienstra, General Manager und Chief Insurance Officer von Hippo Holdings Inc. (HIPO), meldete den Verkauf von 2.341 Stammaktien von Hippo am 15.08.2025 zum Preis von $30,91 pro Aktie. Nach der Transaktion hielt er wirtschaftlich 78.396 Aktien, wovon 46.271 als RSUs ausgewiesen sind. Das Formular 4 wurde am 18.08.2025 von einem Bevollmächtigten unterzeichnet. Die Meldung weist den Transaktionscode F für Verkauf aus und nennt die nachträgliche wirtschaftliche Beteiligung, liefert jedoch keine weiteren Angaben zum Verkaufsgrund oder geplanten Transaktionen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Stienstra Michael

(Last) (First) (Middle)
C/O HIPPO HOLDINGS INC., 1 ALMADEN BLVD

(Street)
SAN JOSE CA 95113

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Hippo Holdings Inc. [ HIPO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
GM & Chief Insurance, HHIP
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/15/2025 F 2,341 D $30.91 78,396(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Includes 46,271 RSUs.
Remarks:
/s /Guy Zeltser, Attorney-in-Fact for Michael Stienstra 08/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Michael Stienstra report on Form 4 for HIPO?

The Form 4 reports a sale of 2,341 shares of Hippo common stock on 08/15/2025 at a price of $30.91 per share.

How many Hippo (HIPO) shares does Michael Stienstra beneficially own after the reported transaction?

He beneficially owned 78,396 shares following the reported sale, which the filing notes includes 46,271 RSUs.

When was the Form 4 for Michael Stienstra signed and filed?

The Form 4 was signed by an attorney-in-fact on 08/18/2025 reporting the transaction dated 08/15/2025.

Does the filing state if the sale was part of a 10b5-1 trading plan?

No. The Form 4 does not identify the transaction as being made pursuant to a 10b5-1 trading plan.

What transaction code is used for the reported sale on the Form 4?

The sale is reported with transaction code F, which indicates a disposition (sale) of securities.
Hippo Hldgs Inc

NYSE:HIPO

HIPO Rankings

HIPO Latest News

HIPO Latest SEC Filings

HIPO Stock Data

782.13M
19.21M
23.24%
47.9%
2.46%
Insurance - Property & Casualty
Fire, Marine & Casualty Insurance
Link
United States
SAN JOSE